WO2004043368A3 - Sulfonamides - Google Patents

Sulfonamides Download PDF

Info

Publication number
WO2004043368A3
WO2004043368A3 PCT/US2003/035357 US0335357W WO2004043368A3 WO 2004043368 A3 WO2004043368 A3 WO 2004043368A3 US 0335357 W US0335357 W US 0335357W WO 2004043368 A3 WO2004043368 A3 WO 2004043368A3
Authority
WO
WIPO (PCT)
Prior art keywords
sulfonamides
urotensin
antagonists
pharmaceutical compositions
relates
Prior art date
Application number
PCT/US2003/035357
Other languages
English (en)
Other versions
WO2004043368A2 (fr
Inventor
Linda S Barton
Christopher T Louer
John Jeffrey Mcatee
Michael J Neeb
Ning Wang
Original Assignee
Smithkline Beecham Corp
Linda S Barton
Christopher T Louer
John Jeffrey Mcatee
Michael J Neeb
Ning Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Linda S Barton, Christopher T Louer, John Jeffrey Mcatee, Michael J Neeb, Ning Wang filed Critical Smithkline Beecham Corp
Priority to AU2003295408A priority Critical patent/AU2003295408A1/en
Publication of WO2004043368A2 publication Critical patent/WO2004043368A2/fr
Publication of WO2004043368A3 publication Critical patent/WO2004043368A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

La présente invention concerne des sulfonamides, des compositions pharmaceutiques les contenant, ainsi que leur utilisation comme antagonistes de l'urotensine II.
PCT/US2003/035357 2002-11-06 2003-11-06 Sulfonamides WO2004043368A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003295408A AU2003295408A1 (en) 2002-11-06 2003-11-06 Sulfonamides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42416202P 2002-11-06 2002-11-06
US42412802P 2002-11-06 2002-11-06
US60/424,128 2002-11-06
US60/424,162 2002-11-06

Publications (2)

Publication Number Publication Date
WO2004043368A2 WO2004043368A2 (fr) 2004-05-27
WO2004043368A3 true WO2004043368A3 (fr) 2004-07-22

Family

ID=32314525

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/035357 WO2004043368A2 (fr) 2002-11-06 2003-11-06 Sulfonamides

Country Status (2)

Country Link
AU (1) AU2003295408A1 (fr)
WO (1) WO2004043368A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9233956B2 (en) 2008-05-06 2016-01-12 Novartis Ag Benzene sulfonamide thiazole and oxazole compounds

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1856305B (zh) 2003-09-26 2010-04-28 埃科特莱茵药品有限公司 用作尾加压素ⅱ拮抗剂的吡啶衍生物
US8067601B2 (en) 2004-10-12 2011-11-29 Actelion Pharmaceticals Ltd. 1-[2-(4-benzyl-4-hydroxy-piperidin-1 -yl )-ethyl]-3-(2-methyl-quinolin- 4-yl)- urea as crystalline sulfate salt
CL2007002097A1 (es) 2006-07-20 2008-01-18 Smithkline Beecham Corp Compuestos derivados de pirrolidina o morfolina antagonistas de urotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar insuficiencia cardiaca congestiva, insuficiencia cardiaca isquemica, angina, isquemia del miocardio, vejiga hiperactiva, asma y/o copd, entre otras.
EP2590957B1 (fr) 2010-07-09 2014-11-12 Pfizer Limited N-sulfonylbenzamides comme inhibiteurs des canaux sodiques voltage-dépendant

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423717B1 (en) * 1996-12-19 2002-07-23 Smithkline Beecham P.L.C. Sulphonamide derivatives, process for their preparation, and their use as medicaments

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423717B1 (en) * 1996-12-19 2002-07-23 Smithkline Beecham P.L.C. Sulphonamide derivatives, process for their preparation, and their use as medicaments
US6599904B2 (en) * 1996-12-19 2003-07-29 Smithkline Beecham P.L.C. Sulphonamide derivatives, process for their preparation, and their use as medicaments

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9233956B2 (en) 2008-05-06 2016-01-12 Novartis Ag Benzene sulfonamide thiazole and oxazole compounds

Also Published As

Publication number Publication date
WO2004043368A2 (fr) 2004-05-27
AU2003295408A1 (en) 2004-06-03
AU2003295408A8 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
EP2415760A3 (fr) Antagonistes du CCR-9
TW200505875A (en) Novel compounds
MXPA03010158A (es) Sulfonamidas.
WO2004092135A3 (fr) Composes therapeutiques
NO20034230D0 (no) 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
NO20052493D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
WO2004069152A3 (fr) ?4,5 glycuronidase et ses utilisations
WO2004033418A3 (fr) Derives d'acide sulfonylamino-acetique
WO2001044239A3 (fr) Biphenyl sulfonamides utilises comme doubles antagonistes des recepteurs de l'angiotensine et de l'endotheline
WO2004096798A3 (fr) Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique
WO2003000187A3 (fr) Nouvelles pyrazolo-pyrimidines et pyrrolo-pyrimidines et leur utilisation
MY134136A (en) Novel compounds comprising jak3 kinase inhibitors
IL175512A0 (en) Methods of preparing aripiprazole crystalline forms
DK1499607T3 (da) 4-(piperidyl- og pyrrolidyl-alkyl-ureido)-quinoliner som urotensin II-receptorantagonister
WO2004026836A8 (fr) Derives de 1-pyridin-4-yl-uree
WO2006133006A3 (fr) 1-methyl-1h-pyrazole-4-carboxamides utiles comme agents chimiotherapeutiques anticancereux
IL166621A0 (en) Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same
WO2004007664A3 (fr) Vecteurs d'acides nucleiques
WO2002094856A3 (fr) Peptidomimetiques et analogues de gpe
WO2005030209A8 (fr) Derives de pyridine et leur utilisation comme antagonistes de l'urotensine ii
WO2002089740A3 (fr) Sulfonamides
WO2004043366A3 (fr) Sulfonamides
WO2006055663A3 (fr) Nouvelle utilisation
WO2004043368A3 (fr) Sulfonamides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AU BA BB BR BZ CA CN CO CR CU DM DZ EC EG GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX NO NZ OM PH PL RO SC SG TN TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP